External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

EACPT 2025

-
Coming soon
07:00 AM
Duration 15mins Helsinki
Relative and absolute bioavailability study of NXT007, a novel haemophilia A treatment, confirms patient flexibility between different injection sites
Anliker-Ort M, Iwase S, Kiialainen A, Hart D, Katial R, Schmitt C

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar